Skip to content
2000
image of Rheumatoid Arthritis and Secondary Plant Metabolites: An Analysis

Abstract

Chronic rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by persistent joint inflammation, progressive joint destruction, and chronic pain. Although modern therapies like disease-modifying antirheumatic medications (DMARDs) can alleviate symptoms, they may also produce side effects. Because of their anti-inflammatory, antioxidant, and immunomodulatory qualities, plant secondary metabolites such as flavonoids, terpenoids, alkaloids, and phenolic acids have attracted attention as prospective RA treatment agents. This review discusses the pathogenesis of RA and provides an overview of various plant secondary metabolites and their biological activities relevant to RA. It highlights preclinical and clinical studies that have investigated the use of plant metabolites in RA management, demonstrating their potential to reduce inflammation, modulate immune responses, and protect joint structures. The review explores the potential molecular targets and mechanisms of action of plant metabolites in RA, including inflammatory mediators, transcription factors, signalling pathways, oxidative stress, immune cell regulation, cell proliferation and apoptosis, cartilage and bone metabolism, and angiogenesis. Additionally, the challenges and considerations in developing plant-based therapies for RA are discussed, such as efficacy and safety, standardization, bioavailability, regulatory approval, and patient compliance. Finally, future perspectives and research directions are outlined, emphasizing the need for further mechanistic studies, preclinical and clinical investigations, formulation strategies, and interdisciplinary collaborations to fully harness the therapeutic potential of plant secondary metabolites in RA management.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971336322250605063028
2025-06-20
2025-12-06

  • From This Site

    /content/journals/crr/10.2174/0115733971336322250605063028
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Smolen J.S. Aletaha D. Barton A. Burmester G.R. Emery P. Firestein G.S. Kavanaugh A. McInnes I.B. Solomon D.H. Strand V. Yamamoto K. Rheumatoid arthritis. Nat. Rev. Dis. Primers 2018 4 1 18001 10.1038/nrdp.2018.1 29417936
    [Google Scholar]
  2. Ngo S.T. Steyn F.J. McCombe P.A. Gender differences in autoimmune disease. Front. Neuroendocrinol. 2014 35 3 347 369 10.1016/j.yfrne.2014.04.004 24793874
    [Google Scholar]
  3. Scott D.L. Wolfe F. Huizinga T.W.J. Rheumatoid arthritis. Lancet 2010 376 9746 1094 1108 10.1016/S0140‑6736(10)60826‑4 20870100
    [Google Scholar]
  4. Sieghart D. Platzer A. Studenic P. Alasti F. Grundhuber M. Swiniarski S. Horn T. Haslacher H. Blüml S. Smolen J. Steiner G. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis. Front. Immunol. 2018 9 876 10.3389/fimmu.2018.00876 29740454
    [Google Scholar]
  5. Vang T. Congia M. Macis M.D. Musumeci L. Orrú V. Zavattari P. Nika K. Tautz L. Taskén K. Cucca F. Mustelin T. Bottini N. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 2005 37 12 1317 1319 10.1038/ng1673 16273109
    [Google Scholar]
  6. Gregersen P.K. Silver J. Winchester R.J. The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 30 11 1205 1213 10.1002/art.1780301102 2446635
    [Google Scholar]
  7. Dultz G. Matheis N. Dittmar M. Röhrig B. Bender K. Kahaly G.J. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 2009 19 2 143 148 10.1089/thy.2008.0301 19090780
    [Google Scholar]
  8. Bottini N. Peterson E.J. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu. Rev. Immunol. 2014 32 1 83 119 10.1146/annurev‑immunol‑032713‑120249 24364806
    [Google Scholar]
  9. Begovich A.B. Carlton V.E.H. Honigberg L.A. Schrodi S.J. Chokkalingam A.P. Alexander H.C. Ardlie K.G. Huang Q. Smith A.M. Spoerke J.M. Conn M.T. Chang M. Chang S.Y.P. Saiki R.K. Catanese J.J. Leong D.U. Garcia V.E. McAllister L.B. Jeffery D.A. Lee A.T. Batliwalla F. Remmers E. Criswell L.A. Seldin M.F. Kastner D.L. Amos C.I. Sninsky J.J. Gregersen P.K. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 2004 75 2 330 337 10.1086/422827 15208781
    [Google Scholar]
  10. Rieck M. Arechiga A. Onengut-Gumuscu S. Greenbaum C. Concannon P. Buckner J.H. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol. 2007 179 7 4704 4710 10.4049/jimmunol.179.7.4704 17878369
    [Google Scholar]
  11. de Brito Rocha S. Baldo D.C. Andrade L.E.C. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Adv. Rheumatol. 2019 59 1 2 10.1186/s42358‑018‑0042‑8 30657101
    [Google Scholar]
  12. Barik R.R. Bhatt L.K. Emerging epigenetic targets in rheumatoid arthritis. Rheumatol. Int. 2021 41 12 2047 2067 10.1007/s00296‑021‑04951‑y 34309725
    [Google Scholar]
  13. Adami G. Viapiana O. Rossini M. Orsolini G. Bertoldo E. Giollo A. Gatti D. Fassio A. Association between environmental air pollution and rheumatoid arthritis flares. Rheumatology (Oxford) 2021 60 10 4591 4597 10.1093/rheumatology/keab049 33470401
    [Google Scholar]
  14. Esberg A. Johansson L. Johansson I. Dahlqvist S.R. Oral Microbiota Identifies Patients in Early Onset Rheumatoid Arthritis. Microorganisms 2021 9 8 1657 10.3390/microorganisms9081657 34442739
    [Google Scholar]
  15. Zhang X. Zhang D. Jia H. Feng Q. Wang D. Liang D. Wu X. Li J. Tang L. Li Y. Lan Z. Chen B. Li Y. Zhong H. Xie H. Jie Z. Chen W. Tang S. Xu X. Wang X. Cai X. Liu S. Xia Y. Li J. Qiao X. Al-Aama J.Y. Chen H. Wang L. Wu Q. Zhang F. Zheng W. Li Y. Zhang M. Luo G. Xue W. Xiao L. Li J. Chen W. Xu X. Yin Y. Yang H. Wang J. Kristiansen K. Liu L. Li T. Huang Q. Li Y. Wang J. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 2015 21 8 895 905 10.1038/nm.3914 26214836
    [Google Scholar]
  16. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003 423 6937 356 361 10.1038/nature01661 12748655
    [Google Scholar]
  17. McInnes I.B. Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011 365 23 2205 2219 10.1056/NEJMra1004965 22150039
    [Google Scholar]
  18. Klareskog L. Padyukov L. Rönnelid J. Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr. Opin. Immunol. 2006 18 6 650 655 10.1016/j.coi.2006.06.004 17010589
    [Google Scholar]
  19. Gravallese EM Bone destruction in arthritis. Ann Rheum Dis 2002 61 Supplement 2 84 86 10.1136/ard.61.suppl_2.ii84
    [Google Scholar]
  20. Skeoch S. Bruce I.N. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat. Rev. Rheumatol. 2015 11 7 390 400 10.1038/nrrheum.2015.40 25825281
    [Google Scholar]
  21. Yuandani J.I. Jantan I. Salim E. Septama A.W. Rullah K. Nainu F. Fasihi Mohd Aluwi M.F. Emran T.B. Roney M. Khairunnisa N.A. Nasution H.R. Fadhil As’ad M. Shamsudin N.F. Abdullah M.A. Marwa Rani H.L. Al Chaira D.M. Aulia N. Mechanistic insights into anti‐inflammatory and immunosuppressive effects of plant secondary metabolites and their therapeutic potential for rheumatoid arthritis. Phytother. Res. 2024 38 6 2931 2961 10.1002/ptr.8147 38600726
    [Google Scholar]
  22. Ramiro S. Gaujoux-Viala C. Nam J.L. Smolen J.S. Buch M. Gossec L. van der Heijde D. Winthrop K. Landewé R. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann. Rheum. Dis. 2014 73 3 529 535 10.1136/annrheumdis‑2013‑204575 24401994
    [Google Scholar]
  23. Burmester G.R. Pope J.E. Novel treatment strategies in rheumatoid arthritis. Lancet 2017 389 10086 2338 2348 10.1016/S0140‑6736(17)31491‑5 28612748
    [Google Scholar]
  24. Bongartz T. Sutton A.J. Sweeting M.J. Buchan I. Matteson E.L. Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006 295 19 2275 2285 10.1001/jama.295.19.2275 16705109
    [Google Scholar]
  25. Mohan N. Edwards E.T. Cupps T.R. Oliverio P.J. Sandberg G. Crayton H. Richert J.R. Siegel J.N. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum. 2001 44 12 2862 2869 10.1002/1529‑0131(200112)44:12<2862:aid‑art474>3.0.co;2‑w 11762947
    [Google Scholar]
  26. Smolen J.S. Aletaha D. McInnes I.B. Rheumatoid arthritis. Lancet 2016 388 10055 2023 2038 10.1016/S0140‑6736(16)30173‑8 27156434
    [Google Scholar]
  27. Wassenberg S. Rau R. Steinfeld P. Zeidler H. Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double‐blind, placebo‐controlled trial. Arthritis Rheum. 2005 52 11 3371 3380 10.1002/art.21421 16255011
    [Google Scholar]
  28. Förger F. Zbinden A. Villiger P.M. Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients. Joint Bone Spine 2016 83 3 341 343 10.1016/j.jbspin.2015.07.004 26617214
    [Google Scholar]
  29. Mariette X. Förger F. Abraham B. Flynn A.D. Moltó A. Flipo R.M. van Tubergen A. Shaughnessy L. Simpson J. Teil M. Helmer E. Wang M. Chakravarty E.F. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann. Rheum. Dis. 2018 77 2 228 233 10.1136/annrheumdis‑2017‑212196 29030361
    [Google Scholar]
  30. Clowse M.E.B. Wolf D.C. Förger F. Cush J.J. Golembesky A. Shaughnessy L. De Cuyper D. Mahadevan U. Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol. J. Rheumatol. 2015 42 12 2270 2278 10.3899/jrheum.140189 26523031
    [Google Scholar]
  31. Aletaha D. Smolen J.S. Diagnosis and Management of Rheumatoid Arthritis. JAMA 2018 320 13 1360 1372 10.1001/jama.2018.13103 30285183
    [Google Scholar]
  32. Zhang F. Wei K. Slowikowski K. Fonseka C.Y. Rao D.A. Kelly S. Goodman S.M. Tabechian D. Hughes L.B. Salomon-Escoto K. Watts G.F.M. Jonsson A.H. Rangel-Moreno J. Meednu N. Rozo C. Apruzzese W. Eisenhaure T.M. Lieb D.J. Boyle D.L. Mandelin A.M. II Boyce B.F. DiCarlo E. Gravallese E.M. Gregersen P.K. Moreland L. Firestein G.S. Hacohen N. Nusbaum C. Lederer J.A. Perlman H. Pitzalis C. Filer A. Holers V.M. Bykerk V.P. Donlin L.T. Anolik J.H. Brenner M.B. Raychaudhuri S. Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 2019 20 7 928 942 10.1038/s41590‑019‑0378‑1 31061532
    [Google Scholar]
  33. Gizinski A.M. Fox D.A. T cell subsets and their role in the pathogenesis of rheumatic disease. Curr. Opin. Rheumatol. 2014 26 2 204 210 10.1097/BOR.0000000000000036 24445478
    [Google Scholar]
  34. Yang Y. Zhang X. Xu M. Wu X. Zhao F. Zhao C. Quercetin attenuates collagen-induced arthritis by restoration of Th17/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect. Int. Immunopharmacol. 2018 54 153 162 10.1016/j.intimp.2017.11.013 29149703
    [Google Scholar]
  35. Lee C.J. Moon S.J. Jeong J.H. Lee S. Lee M.H. Yoo S.M. Lee H.S. Kang H.C. Lee J.Y. Lee W.S. Lee H.J. Kim E.K. Jhun J.Y. Cho M.L. Min J.K. Cho Y.Y. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis. Cell Death Dis. 2018 9 3 401 10.1038/s41419‑018‑0433‑0 29540697
    [Google Scholar]
  36. Pan D. Li N. Liu Y. Xu Q. Liu Q. You Y. Wei Z. Jiang Y. Liu M. Guo T. Cai X. Liu X. Wang Q. Liu M. Lei X. Zhang M. Zhao X. Lin C. Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway. Int. Immunopharmacol. 2018 55 174 182 10.1016/j.intimp.2017.12.011 29268189
    [Google Scholar]
  37. Feng Z.K. Duan H. Liquiritin from glycyrrhiza uralensis attenuating rheumatoid arthritis via reducing inflammation, suppressing angiogenesis, and inhibiting MAPK signaling pathway. J Agric Food Chem 2019 67 10 2856 2864 10.1021/acs.jafc.9b00185
    [Google Scholar]
  38. Ganesan P. Kim B. Ramalingam P. Karthivashan G. Revuri V. Park S. Kim J. Ko Y. Choi D.K. Antineuroinflammatory Activities and Neurotoxicological Assessment of Curcumin Loaded Solid Lipid Nanoparticles on LPS-Stimulated BV-2 Microglia Cell Models. Molecules 2019 24 6 1170 10.3390/molecules24061170 30934561
    [Google Scholar]
  39. Tong L. Zhao Q. Datan E. Lin G.Q. Minn I. Pomper M.G. Yu B. Romo D. He Q.L. Liu J.O. Triptolide: reflections on two decades of research and prospects for the future. Nat. Prod. Rep. 2021 38 4 843 860 10.1039/D0NP00054J 33146205
    [Google Scholar]
  40. Palareti G. Legnani C. Cosmi B. Comparison between different <scp>D</scp> ‐ <scp>D</scp> imer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the <scp>DULCIS</scp> study. Int. J. Lab. Hematol. 2016 38 1 42 49 10.1111/ijlh.12426 26362346
    [Google Scholar]
  41. Ding Y. Zhao Q. Wang L. Pro-apoptotic and anti-inflammatory effects of araloside A on human rheumatoid arthritis fibroblast-like synoviocytes. Chem. Biol. Interact. 2019 306 131 137 10.1016/j.cbi.2019.04.025 31004595
    [Google Scholar]
  42. Liu K. Liu Y. Xu Y. Nandakumar K.S. Tan H. He C. Dang W. Lin J. Zhou C. Asperosaponin VI protects against bone destructions in collagen induced arthritis by inhibiting osteoclastogenesis. Phytomedicine 2019 63 153006 10.1016/j.phymed.2019.153006 31299594
    [Google Scholar]
  43. Yu W.G. Shen Y. Wu J.Z. Gao Y.B. Zhang L.X. YU WG Madecassoside impedes invasion of rheumatoid fibroblast-like synoviocyte from adjuvant arthritis rats via inhibition of NF- κ B-mediated matrix metalloproteinase-13 expression. Chin. J. Nat. Med. 2018 16 5 330 338 10.1016/S1875‑5364(18)30064‑5 29860993
    [Google Scholar]
  44. Liu C. Yang Y. Sun D. Wang C. Wang H. Jia S. Liu L. Lin N. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis. Rejuvenation Res. 2015 18 6 528 542 10.1089/rej.2015.1688 26418168
    [Google Scholar]
  45. Doss H.M. Samarpita S. Ganesan R. Rasool M. Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway. Life Sci. 2018 207 284 295 10.1016/j.lfs.2018.06.013 29908722
    [Google Scholar]
  46. Kwak S.C. Lee C. Kim J.Y. Oh H.M. So H.S. Lee M.S. Rho M.C. Oh J. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression. Biol. Pharm. Bull. 2013 36 11 1779 1786 10.1248/bpb.b13‑00430 23985829
    [Google Scholar]
  47. Wang Y. Gao J. Xing L.Z. Therapeutic potential of Oroxylin A in rheumatoid arthritis. Int. Immunopharmacol. 2016 40 294 299 10.1016/j.intimp.2016.09.006 27643663
    [Google Scholar]
  48. Dinda B. Dinda S. DasSharma S. Banik R. Chakraborty A. Dinda M. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur. J. Med. Chem. 2017 131 68 80 10.1016/j.ejmech.2017.03.004 28288320
    [Google Scholar]
  49. Wang J. Liu W. Luo G. Li Z. Zhao C. Zhang H. Zhu M. Xu Q. Wang X. Zhao C. Qu Y. Yang Z. Yao T. Li Y. Lin Y. Wu Y. Li Y. Synergistic effect of well-defined dual sites boosting the oxygen reduction reaction. Energy Environ. Sci. 2018 11 12 3375 3379 10.1039/C8EE02656D
    [Google Scholar]
  50. Kan X. Hu G. Huang B. Guo W. Huang Y. Chen Y. Xu P. Cai X. Fu S. Liu J. Pedunculoside protects against LPS-induced mastitis in mice by inhibiting inflammation and maintaining the integrity of blood-milk barrier. Aging (Albany NY) 2021 13 15 19460 19474 10.18632/aging.203357 34383710
    [Google Scholar]
  51. Wen H. Yang G. Dong Q. Ellipticine inhibits the proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via the STAT3 pathway. Immunopharmacol. Immunotoxicol. 2017 39 4 219 224 10.1080/08923973.2017.1327963 28555524
    [Google Scholar]
  52. Zhao Y.C. Xue C.H. Zhang T.T. Wang Y.M. Saponins from Sea Cucumber and Their Biological Activities. J. Agric. Food Chem. 2018 66 28 7222 7237 10.1021/acs.jafc.8b01770 29932674
    [Google Scholar]
  53. Kwon O.G. Ku S.K. An H.D. Lee Y.J. The Effects of Platycodin D, a Saponin Purified from Platycodi Radix, on Collagen‐Induced DBA/1J Mouse Rheumatoid Arthritis. Evid. Based Complement. Alternat. Med. 2014 2014 1 954508 10.1155/2014/954508 24511322
    [Google Scholar]
  54. Bao C. Liu Y. Sun X. Xing C. Zeng L. Sun G. Periploca forrestii saponin ameliorates CIA via suppressing proinflammatory cytokines and nuclear factor kappa-B pathways. PLoS One 2017 12 5 e0176672 10.1371/journal.pone.0176672 28463993
    [Google Scholar]
  55. Lestari M.L.A.D. Indrayanto G. Curcumin. Profiles Drug Subst Excip Relat Methodol 2014 39 113 204 10.1016/B978‑0‑12‑800173‑8.00003‑9
    [Google Scholar]
  56. Kshirsagar A.D. Panchal P.V. Harle U.N. Nanda R.K. Shaikh H.M. Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents. Int. J. Inflamm. 2014 2014 1 12 10.1155/2014/690596 25610704
    [Google Scholar]
  57. Sharma P. Kharkwal H. Abdin M.Z. Varma A. A Review on Pharmacological Properties of Aloe Vera SEE PROFILE. Int J Pharm Sci Rev Res 2014 29 2 31 7 www.globalresearchonline.net
    [Google Scholar]
  58. Yagi A. Yu BP. A yagi. Prophylactic aloe components on autoimmune diseases: barbaloin, aloe-emodin, emodin, and fermented butyrate. J. Gastroenterol. Hepatol. Res. 2018 7 2 2535 41
    [Google Scholar]
  59. Minhas AM Khan AU Miana GA Anti-inflammatory actions of Berberis lycium (whole plant) in acute and chronic models of inflammation in mice. The J. Anim. Plant Sci. 2018 28 3 1 7
    [Google Scholar]
  60. Uttra A.M. Alamgeer Shahzad M. Shabbir A. Jahan S. Bukhari I.A. Assiri A.M. Ribes orientale: A novel therapeutic approach targeting rheumatoid arthritis with reference to pro-inflammatory cytokines, inflammatory enzymes and anti-inflammatory cytokines. J. Ethnopharmacol. 2019 237 92 107 10.1016/j.jep.2019.03.019 30872172
    [Google Scholar]
  61. Valerio M. Awad A.B. β-Sitosterol down-regulates some pro-inflammatory signal transduction pathways by increasing the activity of tyrosine phosphatase SHP-1 in J774A.1 murine macrophages. Int. Immunopharmacol. 2011 11 8 1012 1017 10.1016/j.intimp.2011.02.018 21356343
    [Google Scholar]
  62. Chang C.S. Sun H.L. Lii C.K. Chen H.W. Chen P.Y. Liu K.L. Gamma-linolenic acid inhibits inflammatory responses by regulating NF-kappaB and AP-1 activation in lipopolysaccharide-induced RAW 264.7 macrophages. Inflammation 2010 33 1 46 57 10.1007/s10753‑009‑9157‑8 19842026
    [Google Scholar]
  63. Bagde S. Biswas D. A review on some selected traditional indian medicinal plants of immunomodulatory potential and their therapeutic use in rheumatoid arthritis. Int. J. Pharm. Sci. Res. 2019 10 5 2087 2100 10.13040/IJPSR.0975‑8232.10(5).2087‑00
    [Google Scholar]
  64. Lyß G. Knorre A. Schmidt T.J. Pahl H.L. Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J. Biol. Chem. 1998 273 50 33508 33516 10.1074/jbc.273.50.33508 9837931
    [Google Scholar]
  65. Maurya S.K. Raj K. Srivastava A.K. Antidyslipidaemic activity of Glycyrrhiza glabra in high fructose diet induced dsyslipidaemic Syrian golden hamsters. Indian J. Clin. Biochem. 2009 24 4 404 409 10.1007/s12291‑009‑0072‑4 23105868
    [Google Scholar]
  66. Majid M. Nasir B. Zahra S.S. Khan M.R. Mirza B. Haq I. Ipomoea batatas L. Lam. ameliorates acute and chronic inflammations by suppressing inflammatory mediators, a comprehensive exploration using in vitro and in vivo models. BMC Complement. Altern. Med. 2018 18 1 216 10.1186/s12906‑018‑2279‑5 30005651
    [Google Scholar]
  67. Mahdi H.J. Khan N.A.K. Asmawi M.Z. Bin, Mahmud R, A/L Murugaiyah V. In vivo anti-arthritic and anti-nociceptive effects of ethanol extract of Moringa oleifera leaves on complete Freund’s adjuvant (CFA)-induced arthritis in rats. Integr. Med. Res. 2018 7 1 85 94 10.1016/j.imr.2017.11.002 29629295
    [Google Scholar]
  68. Anna A.T. Suhana ME. Das S Faizah O. Anti-inflammatory effect of Curcuma longa (turmeric) on collagen-induced arthritis: An anatomico-radiological study. The Therapeutic Clinic 2011 162 3 201 207
    [Google Scholar]
  69. Kamarudin T.A. Othman F. Mohd Ramli E.S. Md Isa N. Das S. Protective effect of curcumin on experimentally induced arthritic rats: detailed histopathological study of the joints and white blood cell count. EXCLI J. 2012 11 226 236 27366139
    [Google Scholar]
  70. Alvarez L. Rios M.Y. Esquivel C. Chávez M.I. Delgado G. Aguilar M.I. Villarreal M.L. Navarro V. Cytotoxic Isoflavans from Eysenhardtia p olystachya. J. Nat. Prod. 1998 61 6 767 770 10.1021/np970586b 9644061
    [Google Scholar]
  71. Fakurazi S. Fard M.T. Arulselvan P. Karthivashan G. Adam S.K. Bioactive extract from moringa oleifera inhibits the pro-inflammatory mediators in lipopolysaccharide stimulated macrophages. Pharmacogn. Mag. 2015 11 44 Suppl. 4 556 10.4103/0973‑1296.172961 27013794
    [Google Scholar]
  72. Held S. Schieberle P. Somoza V. Characterization of α-terpineol as an anti-inflammatory component of orange juice by in vitro studies using oral buccal cells. J. Agric. Food Chem. 2007 55 20 8040 8046 10.1021/jf071691m 17867636
    [Google Scholar]
  73. Zhu J. Yamane H. Paul W.E. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 2010 28 1 445 489 10.1146/annurev‑immunol‑030409‑101212 20192806
    [Google Scholar]
  74. Magrone T. Jirillo E. Polyphenols from red wine are potent modulators of innate and adaptive immune responsiveness. Proc. Nutr. Soc. 2010 69 3 279 285 10.1017/S0029665110000121 20522276
    [Google Scholar]
  75. Yang J. Yang X. Li M. Baicalin, a natural compound, promotes regulatory T cell differentiation. BMC Complement. Altern. Med. 2012 12 1 64 10.1186/1472‑6882‑12‑64 22591709
    [Google Scholar]
  76. Yang J. Yang X. Chu Y. Li M. Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation. PLoS One 2011 6 2 e17164 10.1371/journal.pone.0017164 21359178
    [Google Scholar]
  77. Wang H.K. Yeh C.H. Iwamoto T. Satsu H. Shimizu M. Totsuka M. Dietary flavonoid naringenin induces regulatory T cells via an aryl hydrocarbon receptor mediated pathway. J. Agric. Food Chem. 2012 60 9 2171 2178 10.1021/jf204625y 22324845
    [Google Scholar]
  78. Sanbongi C. Suzuki N. Sakane T. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell. Immunol. 1997 177 2 129 136 10.1006/cimm.1997.1109 9178639
    [Google Scholar]
  79. Hassanain E. Silverberg J.I. Norowitz K.B. Green tea (Camelia Sinensis) suppresses b cell production of ige without inducing apoptosis. 2010 Available from: www.annclinlabsci.org
  80. Wang K. Ping S. Huang S. Hu L. Xuan H. Zhang C. Hu F. Molecular mechanisms underlying the in vitro anti-inflammatory effects of a flavonoid-rich ethanol extract from chinese propolis (poplar type). Evid. Based Complement. Alternat. Med. 2013 2013 1 11 10.1155/2013/127672 23401705
    [Google Scholar]
  81. Lai Z.R. Ho Y.L. Huang S.C. Huang T.H. Lai S.C. Tsai J.C. Wang C.Y. Huang G.J. Chang Y.S. Antioxidant, anti-inflammatory and antiproliferative activities of Kalanchoe gracilis (L.) DC stem. Am. J. Chin. Med. 2011 39 6 1275 1290 10.1142/S0192415X1100955X 22083996
    [Google Scholar]
  82. Park K.I. Kang S.R. Park H.S. Lee D.H. Nagappan A. Kim J.A. Shin S.C. Kim E.H. Lee W.S. Chung H.J. An S.J. Kim G.S. Regulation of Proinflammatory Mediators via NF- κ B and p38 MAPK-Dependent Mechanisms in RAW 264.7 Macrophages by Polyphenol Components Isolated from Korea Lonicera japonica THUNB. Evid. Based Complement. Alternat. Med. 2012 2012 1 10 10.1155/2012/828521 22611435
    [Google Scholar]
  83. Chiva-Blanch G. Urpi-Sarda M. Llorach R. Rotches-Ribalta M. Guillén M. Casas R. Arranz S. Valderas-Martinez P. Portoles O. Corella D. Tinahones F. Lamuela-Raventos R.M. Andres-Lacueva C. Estruch R. Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial. Am. J. Clin. Nutr. 2012 95 2 326 334 10.3945/ajcn.111.022889 22205309
    [Google Scholar]
  84. Libby P. Ridker P.M. Maseri A. Inflammation and Atherosclerosis. Circulation 2002 105 9 1135 1143 10.1161/hc0902.104353 11877368
    [Google Scholar]
  85. Halevy O. Nagler A. Levi-Schaffer F. Genina O. Pines M. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: Effect of halofuginone. Biochem. Pharmacol. 1996 52 7 1057 1063 10.1016/0006‑2952(96)00427‑3 8831725
    [Google Scholar]
  86. Wang Z. Yang Z. Zhang L. Wang X. Peng C. Meng D. Yan D. Toxic effects of vinca alkaloids from Catharanthus roseus (L.) G. Don on Tetrahymena thermophila BF 5 growth by microcalorimetry. Thermochim. Acta 2017 651 53 57 10.1016/j.tca.2017.02.018
    [Google Scholar]
  87. Luo Y. Liu M. Xia Y. Dai Y. Chou G. Wang Z. Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, on collagen-induced arthritis in mice. Phytomedicine 2010 17 10 726 731 10.1016/j.phymed.2010.01.013 20363113
    [Google Scholar]
  88. Yuan X. Tong B. Dou Y. Wu X. Wei Z. Dai Y. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor. Biochem. Pharmacol. 2016 101 87 99 10.1016/j.bcp.2015.11.025 26640276
    [Google Scholar]
  89. Farinon M. Clarimundo V.S. Pedrazza G.P.R. Gulko P.S. Zuanazzi J.A.S. Xavier R.M. de Oliveira P.G. Disease modifying anti-rheumatic activity of the alkaloid montanine on experimental arthritis and fibroblast-like synoviocytes. Eur. J. Pharmacol. 2017 799 180 187 10.1016/j.ejphar.2017.02.013 28192100
    [Google Scholar]
  90. Tong W.W. Zhang C. Hong T. Liu D.H. Wang C. Li J. He X.K. Xu W.D. Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats. Sci. Rep. 2018 8 1 3241 10.1038/s41598‑018‑21674‑6 29459717
    [Google Scholar]
  91. Yi Z. Ran Y. Chen X. Tong Q. Ma L. Tan Y. Ma X. Li X. Tea polyphenol carrier-enhanced dexamethasone nanomedicines for inflammation-targeted treatment of rheumatoid arthritis. J. Mater. Chem. B Mater. Biol. Med. 2023 11 48 11505 11518 10.1039/D3TB02316H 38038124
    [Google Scholar]
  92. Zhang J. Song X. Cao W. Lu J. Wang X. Wang G. Wang Z. Chen X. Autophagy and mitochondrial dysfunction in adjuvant-arthritis rats treatment with resveratrol. Sci. Rep. 2016 6 1 32928 10.1038/srep32928 27611176
    [Google Scholar]
  93. Kim H.R. Rajaiah R. Wu Q.L. Satpute S.R. Tan M.T. Simon J.E. Berman B.M. Moudgil K.D. Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. J. Nutr. 2008 138 11 2111 2116 10.3945/jn.108.089912 18936206
    [Google Scholar]
  94. Fernández-Rodríguez J.A. Almonte-Becerril M. Ramil-Gómez O. Hermida-Carballo L. Viñas-Diz S. Vela-Anero Á. Concha Á. Camacho-Encina M. Blanco F.J. López-Armada M.J. Autophagy Activation by Resveratrol Reduces Severity of Experimental Rheumatoid Arthritis. Mol. Nutr. Food Res. 2021 65 2 2000377 10.1002/mnfr.202000377 33184983
    [Google Scholar]
  95. Riveiro-Naveira R.R. Valcárcel-Ares M.N. Almonte-Becerril M. Vaamonde-García C. Loureiro J. Hermida-Carballo L. López-Peláez E. Blanco F.J. López-Armada M.J. Resveratrol lowers synovial hyperplasia, inflammatory markers and oxidative damage in an acute antigen-induced arthritis model. Rheumatology (Oxford) 2016 55 10 1889 1900 10.1093/rheumatology/kew255 27354682
    [Google Scholar]
  96. Yang G. Lyu L. Wang X. Bao L. Lyu B. Lin Z. Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway. Pulm. Pharmacol. Ther. 2019 56 69 74 10.1016/j.pupt.2019.03.011 30930172
    [Google Scholar]
  97. Poonia N. Lather V. Kaur B. Kirthanashri S.V. Pandita D. Optimization and Development of Methotrexate- and Resveratrol-Loaded Nanoemulsion Formulation Using Box–Behnken Design for Rheumatoid Arthritis. Assay Drug Dev. Technol. 2020 18 8 356 368 10.1089/adt.2020.989 33052698
    [Google Scholar]
  98. Mirza F. Lorenzo J. Drissi H. Lee F.Y. Soung D.Y. Dried plum alleviates symptoms of inflammatory arthritis in TNF transgenic mice. J. Nutr. Biochem. 2018 52 54 61 10.1016/j.jnutbio.2017.10.002 29149648
    [Google Scholar]
  99. Cai H Zheng Z Sun Y Liu Z Zhang M Li C The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats. Drug Des Devel Ther 2015 4931 10.2147/DDDT.S90147
    [Google Scholar]
  100. Lu B. Li C. Jing L. Zhuang F. Xiang H. Chen Y. Huang B. Rosmarinic acid nanomedicine for rheumatoid arthritis therapy: Targeted RONS scavenging and macrophage repolarization. J. Control. Release 2023 362 631 646 10.1016/j.jconrel.2023.09.012 37708976
    [Google Scholar]
  101. Li D. Zhong Z. Ko C.N. Tian T. Yang C. From mundane to classic: Sinomenine as a multi‐therapeutic agent. Br. J. Pharmacol. 2023 bph.16267 10.1111/bph.16267 37846470
    [Google Scholar]
  102. Okamoto H. Hoshi D. Kiire A. Yamanaka H. Kamatani N. Molecular targets of rheumatoid arthritis. Inflamm. Allergy Drug Targets 2008 7 1 53 66 10.2174/187152808784165199 18473901
    [Google Scholar]
  103. Ghorbani A. Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J. Tradit. Complement. Med. 2017 7 4 433 440 10.1016/j.jtcme.2016.12.014 29034191
    [Google Scholar]
  104. Reflection paper on botanical products used for weight loss and weight management. Amsterdam, Netherlands European Medicines Agency 2019
    [Google Scholar]
  105. Paranjpe P. Kulkarni P.H. Comparative efficacy of four Ayurvedic formulations in the treatment of acne vulgaris: a double-blind randomised placebo-controlled clinical evaluation. J. Ethnopharmacol. 1995 49 3 127 132 10.1016/0378‑8741(95)01309‑1 8824737
    [Google Scholar]
/content/journals/crr/10.2174/0115733971336322250605063028
Loading
Rheumatoid Arthritis and Secondary Plant Metabolites: An Analysis
Bentham Science Publishers ; https://doi.org/10.2174/0115733971336322250605063028
/content/journals/crr/10.2174/0115733971336322250605063028
/content/journals/crr/10.2174/0115733971336322250605063028
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: secondary plant metabolites ; immunomodulatory properties ; anti-inflammatory ; Rheumatoid arthritis ; anti-oxidant ; joints

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test